Furthermore, CA has been shown to inhibit Aβ aggregation, reduce tau phosphorylation, and enhance synaptic plasticity, all of which are critical targets for mitigating the progression of AD [6,9,10]. The gene discussed is MAPT; the disease is Alzheimer disease.